Fen Li Selected Research

dihydrolipoamide succinyltransferase

4/2012

[Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fen Li Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2013
17	Rheumatoid Arthritis 01/2022 - 03/2006
10	Nasopharyngeal Carcinoma 08/2022 - 01/2013
9	Inflammation (Inflammations) 01/2022 - 01/2015
8	Squamous Cell Carcinoma of Head and Neck 05/2019 - 01/2013
6	Ankylosing Spondylitis 03/2022 - 01/2020
6	Congenital Heart Defects (Congenital Heart Defect) 01/2018 - 11/2004
5	Carcinogenesis 01/2022 - 01/2015
5	Infections 01/2020 - 01/2008
5	Insulin Resistance 01/2020 - 11/2015
5	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2014
4	Autoimmune Diseases (Autoimmune Disease) 08/2022 - 09/2010
4	Obesity 06/2021 - 07/2007
4	Pain (Aches) 01/2021 - 05/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2015
4	Patent Ductus Arteriosus 01/2018 - 04/2004
4	Pulmonary Artery Stenosis 05/2014 - 11/2004
3	Fibrosis (Cirrhosis) 08/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 11/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
3	Sepsis (Septicemia) 01/2022 - 10/2018
3	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2021 - 12/2011
3	Hypoxia (Hypoxemia) 01/2021 - 06/2008
3	Myopia 01/2020 - 01/2017
3	Char syndrome 01/2018 - 10/2011
3	Tuberculosis (Tuberculoses) 08/2014 - 09/2011
3	Pathologic Constriction (Stenosis) 05/2014 - 04/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
2	Fatigue 01/2022 - 10/2019
2	Critical Illness (Critically Ill) 01/2022 - 11/2020
2	Allergic Rhinitis 01/2022 - 08/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 01/2021
2	COVID-19 03/2021 - 11/2020
2	Pulmonary Arterial Hypertension 03/2021 - 01/2018
2	Stroke (Strokes) 02/2020 - 01/2017
2	Tetralogy of Fallot (Fallot Tetralogy) 01/2020 - 12/2011
2	Diabetes Mellitus 01/2020 - 07/2007
2	Hypertension (High Blood Pressure) 01/2020 - 07/2007
2	Lymphatic Metastasis 01/2019 - 06/2014
2	Tachycardia (Tachyarrhythmias) 12/2018 - 04/2009
2	Necrosis 10/2018 - 09/2011
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 12/2008
2	Gout 09/2016 - 03/2012

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
6	Pharmaceutical PreparationsIBA 01/2021 - 08/2018
6	Biological ProductsIBA 01/2020 - 02/2014
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2011
5	Therapeutic UsesIBA 08/2020 - 04/2009
4	CytokinesIBA 01/2022 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 06/2012
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 09/2018
4	Insulin (Novolin)FDA Link 01/2020 - 11/2015
4	Infliximab (Remicade)FDA Link 08/2019 - 10/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 07/2007
3	iguratimodIBA 08/2022 - 01/2020
3	Adalimumab (Humira)FDA Link 03/2022 - 01/2020
3	Biosimilar PharmaceuticalsIBA 03/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 09/2010
3	AntibodiesIBA 11/2021 - 03/2006
3	Uric Acid (Urate)IBA 01/2021 - 03/2012
3	3,3'-diindolylmethane (diindolylmethane)IBA 02/2016 - 06/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014 - 01/2008
2	Long Noncoding RNAIBA 08/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2021
2	QuercetinIBA 01/2022 - 12/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2022
2	Rheumatoid FactorIBA 11/2021 - 10/2010
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2021 - 05/2018
2	AlbuminsIBA 07/2021 - 01/2021
2	Vasodilator Agents (Vasodilators)IBA 03/2021 - 12/2011
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2018
2	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2018
2	Ferritins (Ferritin)IBA 01/2021 - 01/2019
2	ChemokinesIBA 01/2020 - 09/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2008
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2019
2	LigandsIBA 01/2020 - 09/2019
2	Tumor Biomarkers (Tumor Markers)IBA 09/2019 - 02/2019
2	Capsules (Microcapsules)IBA 08/2019 - 01/2019
2	Leflunomide (Arava)FDA LinkGeneric 08/2019 - 09/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019 - 06/2012
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2019 - 01/2017
2	IronIBA 01/2019 - 05/2018
2	SmokeIBA 08/2018 - 05/2010
2	CalpainIBA 08/2018 - 04/2017
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2018 - 12/2011
2	MonocrotalineIBA 01/2018 - 05/2004
2	LuciferasesIBA 01/2018 - 07/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 01/2016
2	Polysaccharides (Glycans)IBA 09/2017 - 06/2016
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2017

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2004
4	Length of Stay 01/2021 - 12/2007
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 12/2007
3	Stents 05/2014 - 04/2009
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 03/2021 - 02/2016